{"data":[{"accessionNo":"0002100119-26-001342","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000898437","issuerName":"Anika Therapeutics Inc","ticker":"ANIK","cusip":"035255108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":659216,"percentOfClass":4.95,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0002052113-26-000740","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0000898437","issuerName":"ANIKA THERAPEUTICS INC","ticker":"ANIK","cusip":"035255108","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":544710,"percentOfClass":4.1,"filedAt":"2026-07-17","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0002100119-26-000113","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000898437","issuerName":"Anika Therapeutics Inc","ticker":"ANIK","cusip":"035255108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":695697,"percentOfClass":5.19,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0000102909-26-000682","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0000898437","issuerName":"Anika Therapeutics Inc","ticker":"ANIK","cusip":"035255108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0000902664-26-000511","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-23","reportingPerson":"Caligan Partners LP","reportingCik":"0001727492","personType":"IA,PN","sharesOwned":1435130,"percentOfClass":9.95,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0000902664-26-000511","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-01-23","reportingPerson":"David Johnson","reportingCik":"0001785557","personType":"IN","sharesOwned":1435130,"percentOfClass":9.95,"filedAt":"2026-01-27","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Trigran Investments, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Douglas T. Granat","reportingCik":null,"personType":"HC,IN","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Lawrence A. Oberman","reportingCik":null,"personType":"HC,IN","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Steven G. Simon","reportingCik":null,"personType":"HC,IN","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Bradley F. Simon","reportingCik":null,"personType":"HC,IN","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-26-002059","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-12-31","reportingPerson":"Steven R. Monieson","reportingCik":null,"personType":"HC,IN","sharesOwned":168400,"percentOfClass":1.2,"filedAt":"2026-01-08","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0000902664-25-005133","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-11-19","reportingPerson":"Caligan Partners LP","reportingCik":"0001727492","personType":"IA,PN","sharesOwned":1435130,"percentOfClass":9.95,"filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0000902664-25-005133","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-11-19","reportingPerson":"David Johnson","reportingCik":"0001785557","personType":"IN","sharesOwned":1435130,"percentOfClass":9.95,"filedAt":"2025-11-21","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Trigran Investments, Inc.","reportingCik":null,"personType":"IA,CO","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Douglas T. Granat","reportingCik":null,"personType":"HC,IN","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Lawrence A. Oberman","reportingCik":null,"personType":"HC,IN","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Steven G. Simon","reportingCik":null,"personType":"HC,IN","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Bradley F. Simon","reportingCik":null,"personType":"HC,IN","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0001104659-25-108057","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0000898437","issuerName":"Anika Therapeutics, Inc.","ticker":"ANIK","cusip":null,"securityClass":"Common Stock, Par Value $0.01 Per Share","eventDate":"2025-09-30","reportingPerson":"Steven R. Monieson","reportingCik":null,"personType":"HC,IN","sharesOwned":1621215,"percentOfClass":11.2,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/anik"},{"accessionNo":"0002052113-25-003599","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0000898437","issuerName":"ANIKA THERAPEUTICS INC","ticker":"ANIK","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":793359,"percentOfClass":5.5,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/anik"}],"updatedAt":"2026-11-04T00:33:36.141Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/anik","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}